Why Doctors Hate Unscheduled MR Visits More Than MRs Do

Following up on what we noticed in FieldVoice's voice logs, we spent time in the last few weeks talking to doctors directly about unscheduled medical rep visits, rather than inferring their frustration secondhand from a rep's notes. The picture that emerged was sharper than we expected.

It is not really about time

Our first assumption was that doctors object to unscheduled visits purely because they are busy, which is true but incomplete. What came up more often was a lack of control over their own day. A doctor running a clinic manages a schedule built around patients, and an unannounced rep visit forces a choice in real time: interrupt a patient consultation, make the rep wait indefinitely, or turn them away and possibly damage a relationship that matters for both sides. None of those options is good, and the doctor bears that decision cost every single time, not the rep.

Why MRs do not mind as much

Reps generally view drop-in visits as simply how the job works, since a missed or refused visit this week can often be tried again next week with limited consequence. For a doctor, every interruption during patient hours has an immediate, visible cost, whether that is a longer waiting room or a rushed consultation. The asymmetry is the whole problem: the person absorbing the cost of an unscheduled visit is not the person deciding when it happens.

What doctors actually asked for

• •A way to know in advance, even a day or a few hours ahead, that a rep intends to visit
• •Some assurance the visit will happen within a specific, agreed window rather than an open-ended stretch of the day
• •The option to decline or reschedule without it reading as a rejection of the pharma relationship itself

None of this is a request to see fewer reps. Doctors were consistently clear that the relationship itself has value to them too. The request was narrower: predictability, not less access.

We are now sketching out what a scheduling product for this would look like, one that gives doctors real control over when visits happen while still working within how pharma companies organize their field teams. It is early, and there is nothing built yet worth describing in detail. But the doctors we spoke with described the problem clearly enough that we think it is worth solving properly rather than quickly.